Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Crown Energy AB: Interim Report, January-March 2019

Q1 – JANUARY-MARCH 2019 · Revenue amounted to SEK 13,046 thousand (20,599). · Operating profit amounted to SEK 3,002 thousand (7,029). · Unrealised changes in property values amounted to SEK -30,061 thousand (18,538). · Profit before tax was SEK -2,865 thousand (42,287), and profit after tax was SEK -22,239 thousand (9,367), corresponding to SEK -0.05 (0.02) per share. KEY EVENTS JANUARY-MARCH 2019 · On February 1, 2019, 40 per cent of the ownership in the Maria property was transferred, from being leased, to Crown Energy. The transfer was made without any

Eniro interim report January – March 2019

Eniro publishes the interim report for the first quarter 2019. The report is available on the company’s website www.enirogroup.com.   FIRST QUARTER: JANUARY- MARCH 2019   · Total operating revenue amounted to SEK 275 M (354), a decrease with 22%. Excluding Eniro Polska, which was divested in October 2018, the decrease amounted to 10%. · EBITDA amounted to SEK 24 M (48). The EBITDA margin was 8.7% (13.6%). Adjusted EBITDA amounted to SEK 24 M (49). · Net income for the period was SEK -38 M (3). · Earnings per ordinary share for the period were SEK -0.59 (0.03) before and

Viking Supply Ships AB (Publ) Interim report Q1 2019

Press release  9 May 2019FIRST QUARTER                                                                                                                                             · Total revenue from continuing operations was MSEK 78 (84) ·  EBITDA from continuing operations was MSEK -22 (-22) ·  Result after tax including discontinued operations was MSEK -17 (-85) ·  Result after tax per share including discontinued operations was SEK -1.8 (-10.0) SUMMARY OF EVENTS IN Q1  ·  EBITDA for Q1 from continuing operations was MSEK -22 (-22). ·  The average fixture rate

ORGANOCLICK PUBLISH ITS INTERIM REPORT FOR Q1 2019

"We have once again wind in our tail with a sales growth of 20 % during the quarter, totalling sales of SEK 22.1 (18.4) million. Our new customers are now generating sales for us but we have also grown with our existing customers. Both the business unit Green coatings & maintenance products as well as Functional wood have a strong growth, but our other product segments are beginning to start up. A changed product mix improves our gross margin (after variable costs) to 46 (44) %. The leverage in our business can now also be clearly seen as we have been able to reduce our operating cost with

Proposal for new Board at the AGM on 23 May 2019

Net Gaming Europe’s principal owner Trottholmen AB hereby submits proposals for Board fees (item 11) and election to the Board (items 12 and 13) prior to the Annual General Meeting on 23 May 2019.Trottholmen AB proposes that the Board shall consist of five (5) members (item 12) and that Board fees of SEK 160,000 shall be paid to each non-executive Board member. The Chairman of the Remuneration or Audit Committee shall be paid fees of SEK 40,000. Members of the Remuneration or Audit Committee shall each be paid fees SEK 20,000 (item 11). Trottholmen AB also proposes the re-election of

Pandox AB (publ) adjusts dividend policy

To capture growth opportunities while at the same time maintaining a strong financial position, Pandox has decided to adjust its dividend policy. Pandox’s new target is a dividend pay-out ratio of 30-50 percent (previously 40-60 percent) of total cash earnings (*), with an average dividend pay-out ratio over time of approximately 40 percent (previously approximately 50 percent).Pandox will remain a company with good returns and a balanced financial risk. Pandox’s management and board expect that the new dividend policy will contribute positively to the company’s possibilities to create

Pandox’s platform for value creation in focus at today’s capital markets day

Pandox AB (publ) is today arranging a capital markets day in Stockholm. During the day Pandox’s strategic position and the company’s growth drivers will be described. The starting point is Pandox’s platform for value creation which has contributed to the company having been able to grow faster than the hotel market over time.Participants from Pandox are Anders Nissen (CEO), Liia Nõu (CFO), Jonas Törner (SVP Business Intelligence), Caroline Tivéus (Director of Sustainable Business) and Anders Berg (SVP Communications and IR).Agenda (CEST) 12:00 Registration13:00 Presentations (

SolunoBC expands further into the Finnish UCaaS market

SolunoBC, the largest operator independent UCaaS provider in the Nordic market, has signed an agreement with Finnish Taika Company to take over existing cooperation agreements to ensure growth in the Finnish market, concerning all services in Soluno’s brand and service portfolio. Soluno will change strategy how to go to market in Finland, going from being a platform supplier, in a former cooperation with Taika, to taking full commercial responsibility for all the resellers. Soluno takes another important step in its European expansion following earlier establishing into Netherlands,

Dustin’s CEO increases his shareholding through subscription for new shares in incentive program

Dustin CEO Thomas Ekman has subscribed for 25,500 new shares through warrants purchased in the long-term incentive program introduced at the annual general meeting on January 19, 2016. After the subscription of new shares Thomas Ekman will hold a total of 33,500 shares in the company. Contact person: Eva Ernfors, Head of Information; eva.ernfors@dustin.se, +46 70 258 62 94 About Dustin Dustin is a leading online based IT-partner with operations in the Nordics and the Netherlands. The Company offers IT products with associated services and solutions to companies, the public

Interim Report January – March 2019

Solid financial result. Startup of ZYN production in the US · In local currencies, sales increased by 3 percent for the first quarter. Reported sales increased by 11 percent to 3,258 MSEK (2,941). · In local currencies, operating profit from product segments1) increased by 7 percent for the first quarter. Reported operating profit from product segments increased by 15 percent to 1,238 MSEK (1,079). · Operating profit amounted to 1,190 MSEK (1,047) for the first quarter. · Profit after tax amounted to 880 MSEK (766) for the first quarter. · Earnings per share increased by 19

Photocure ASA: Invitation to first quarter 2019 results presentation and webcast

Photocure will present its first quarter report on Tuesday 14 May 2019 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET).Representatives from the company will be Daniel Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English. The quarterly report and presentation will be published at 07:00 CET and will be publicly available at www.photocure.com. It will be possible to follow the presentation through https://webtv.hegnar.no/presentation.php?webcastId=97815786.  A light snack will be served from 08:00 (CET). The presentation is scheduled

Norway Royal Salmon: Notice to Annual General Meeting

Attached please find the notice to the Annual General Meeting in Norway Royal Salmon ASA (the "Company"), to be held in Trondheim 6(th) June 2019. The notice will be sent to all shareholders by post no later than 10(th) May 2019. The board of directors proposes a distribution of dividend for 2018 of NOK 6.00 per share, by the way of a cash distribution of NOK 4.20 per share and distribution of shares in the Company from the Company's treasury shares. The number of shares for distribution in total and per outstanding share will be decided based on the shares' volume weighted average

Humana reports first quarter results 2019

A good start to the year clouded by challenges in Individual & FamilyFirst quarter, January - March 2019  ·  Operating revenue was SEK 1,708 M (1,648), an increase of 4%. ·  Operating profit was SEK 77 M (81), a decrease of 5%. Excluding the effects of IFRS 16, which apply from 1 January 2019, the operating profit amounted to SEK 70 M (81). ·  Net profit after tax for the period amounted to SEK 44 M (45). ·  Earnings per share for the period before and after dilution amounted to SEK 0.83 (0.85). ·  Operating cash flow amounted to SEK 33 M (-32). Excluding the effects of

Ziccum Q1 Report 2019 released

(Stockholm May 9, 2019)  Ziccum AB today releases its Q1 Report for 2019. The Report is now available on the company’s website.Summary of interim report - first quarter 2019: Successful development of a dry, temperature-stable formulation of Adenovirus resulted in a filed patent application and a significant milestone for Ziccum. Dialogue with potential Customers and partners continue with increased intensity, and an application has been submitted to Horizon 2020 step 2. January - March 2019 Net sales SEK 0,0 (190) Operating profit SEK -1,689 thousand (-137) Earnings per share

Annual General Meeting in Fastighets AB Balder (PUBL)

The Annual General Meeting (AGM) of Fastighets AB Balder (publ) was held on 8 May, 2019 in Gothenburg.Christina Rogestam, Chairman of the Board, opened the meeting and was elected Chairman of the AGM.Erik Selin, CEO, reported on the company´s operations during 2018.The income statement and the balance sheet as well as the consolidated income statement and the consolidated balance sheet for 2018 were adopted. The Board members and the CEO were discharged from liability for their administration during the 2018 fiscal year.The AGM resolved that the shareholders shall not obtain any

Invitation to presentation in conjunction with Net Gaming's first quarter of 2019

On Thursday 23 May at 08:30 a.m. CET Net Gaming's interim report for the first quarter of 2019, will be published. At 10:00 a.m. the same day a presentation of Net Gaming's interim report for the first quarter of 2019, will be presented.CEO Marcus Teilman and CFO Gustav Vadenbring will present the results, followed by a Q&A session. The presentation will be held in English and will be webcasted live through netgaming.se or via https://tv.streamfabriken.com/net-gaming-europe-q1-2019 The join the conference via phone, please dial-in using any of the numbers below: From Sweden:

Interim report for Q1 2019

A stable beginning of the yearThe beginning of 2019 was stable. Revenues increased somewhat, while the EBITDA result and margin greatly improved. 2018 was an exciting and eventful year for Bactiguard when we reached several important milestones, so we have high expectations for 2019.First quarter (January-March 2019) · Revenues amounted to SEK 35.1 (33.0) million, an increase mainly driven by higher license revenues. · BIP sales amounted to SEK 3.1 (7.3) million. No deliveries were made to China and India this quarter, while first quarter of 2018 contained major deliveries to both

Clavister Q1 2019: 38% growth

May 9, 2019. Örnsköldsvik, Sweden. Clavister, a leader in high-performance cybersecurity solutions, released its Q1 2019 interim report today.“The first quarter of the year provided for a 38% order intake growth, year-on-year.Our focus markets Nordics and the DACH region continued to demonstrate high growth, and in DACH specifically we were able to on-board a significant number of new reseller partners.Apart from a relentless focus on sales growth, the year for Clavister will be dominated by a flood of new and exciting product launches. 2019 alone will see more new products from

Annual General Meeting of BioGaia

The Annual General Meeting of BioGaia AB (publ) on 8 May 2019 voted, among other things, to approve the following resolutions: · adoption of the annual report · discharge from liability for the Board members and the Managing Director · a dividend of SEK 10.00 per share and a grant of SEK 3.2 million to “The foundation to prevent antibiotic resistance” that was founded by BioGaia in 2017. The purpose of the foundation is to reduce antibiotic resistance through support to research, education and information activities that promote of the use of products and methods that prevent

Interim report for the period January 1 - March 31, 2019

Net sales increased during the quarter to SEK 22.5 million (0.0) and operating profit improved to SEK -16.9 million (-20.1) attributable to deliveries within geothermal. The increase in value in Baseload Capital resulted in an improved profit after financial items SEK -7.3 million (-20.5). However, external factors in the form of customers' permitting processes within geothermal remain a challenge that extends current lead times. In total, the order backlog amounted to SEK 799.3 million (404.3) at the end of the quarter.FIRST QUARTER 2019 JANUARY – MARCH · Net sales increased to SEK

Angler Gaming plc - Interim Report for 1st Quarter of 2019

EBIT increased by 70% compared to the previous quarter (Q4 2018)· Revenues increased by 56.47% to €6,303,333 (Q1 2018: €4,028,577) · EBIT decreased by 11.17% to €1,216,127 (Q1 2018: €1,369,075) · EBIT increased by 70.06% compared to Q4 2018 (Q4 2018: € 715,128) · EBIT margin of 19.29% (Q1 2018: 33.98%) · Customer deposits increase of 141.22% to €16,324,713 (Q1 2018: €6,767,565) · 36,100 new registered customers (Q1 2018: 35,237), an increase of 2.45% · 33,303 active customers (Q1 2018: 21,203), an increase of 57.07%. · Earnings per share of €0.0146 (Q1 2018: €0.0178).

Interim Report January – March 2019

BioArctic’s partner Eisai initiated Phase 3-study with BAN2401 in Alzheimer’s disease. Phase 1-study with ABBV-0805 in the Parkinson program startedFinancial summary for the period January – March 2019 · Net revenues for the period amounted to MSEK 63.4 (52.3), which is an increase of MSEK 11.1 · Operating profit amounted to MSEK 17.3 (18.9), a decrease of MSEK 1.6. The operating margin was 27.3 percent (36.1) · Profit for the period amounted to MSEK 13.6 (15.4) and earnings per share1were SEK 0.15 (0.18) · Cash flow from operating activities amounted to MSEK 333.6 (-42.0)

Nuevolution’s BET-BD1 selective inhibitor and candidate compound, NUE20798, shows positive effect on disease scoring and biomarker levels in an atopic dermatitis (eczema) mouse model

Stockholm, 9 May 2019. Nuevolution AB (publ) (NUE.ST) today announced completion of positive data for NUE20798 from an atopic dermatitis (eczema) mouse model showing reduction of both disease - and clinical biomarker levels. No negative effect was observed on the blood platelet count (so-called thrombocytopenia) when using Nuevolution’s selective bromodomain inhibitor NUE20798. Nuevolution has developed potent and selective compounds, with a benign safety profile targeting the first bromodomain of the BET family of proteins and recently nominated NUE20798 as its development candidate.

Increased number of shares entered into trade register

Revenio Group Corporation, Stock Exchange Release, May 9, 2019 at 9:00INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER Total of 6,270 new share subscriptions based on the company's 2015A stock options approved by the Board of Directors of Revenio Group Corporation on April 29, 2019, have been entered into the trade register today. The share subscription price under 2015A option rights was 7.95 EUR per share. The subscription period for 2015A options is May 31, 2017 – May 31, 2019. After these subscriptions, the number of Revenio Group Corporation's shares and votes will rise to

There are no items matching the current filter
There are no more items matching the current filter
Back to top